期刊
SCHIZOPHRENIA RESEARCH
卷 115, 期 1, 页码 17-23出版社
ELSEVIER
DOI: 10.1016/j.schres.2009.08.016
关键词
Antipsychotic; Emotion perception; Schizophrenia; Social cognition; Pharmacological treatment
类别
资金
- NIMH NIH HHS [R34 MH071252, R34 MH071252-03, N01MH90001, N01 MH90001, R34 MH080010, N01 MH-90001, R34 MH080010-03] Funding Source: Medline
Few pharmacological intervention studies have examined the impact of medication on social cognition, particularly emotion perception. The goal of this randomized, double-blind study is to compare the effects of several second generation antipsychotics and a first generation antipsychotic, perphenazine, on emotion perception in individuals with schizophrenia. Patients were assigned to receive treatment with olanzapine, queitapine fumarate, risperidone, ziprasidone or perphenazine for up to 18 months. Eight hundred and seventy three patients completed an emotion perception test immediately prior to randomization and after 2 months of treatment. We also examined baseline predictors of emotion perception change. Most treatments were associated with a small, non-statistically significant improvement in emotion perception at two months, although they did not differ from one another. Greater improvement in emotion perception at 2 months was significantly predicted by lower baseline emotion perception and higher baseline neurocognitive functioning, and marginally predicted by less time on an antipsychotic. (C) 2009 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据